Immune Pharmaceuticals immunepharmaceuticals.com

Immune Pharmaceuticals (OTCQX: EPCTD, Nasdaq OMX Stockholm Exchange: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The company's lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for severe asthma, Crohn's disease and certain ophthalmologica...Show all

Immune Pharmaceuticals (OTCQX: EPCTD, Nasdaq OMX Stockholm Exchange: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. ...Show all

See All Exits Recent Exits

Phone: 914-606-3501

Fax:

777 Old Saw Mill Road

Tarrytown, 10591
New York, United States

Immune Pharmaceuticals - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2013-08-26EpiCeptMerger
See all 1 investments